Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges

References

• Evans M. Uveitis. In: Yanoff M, Duker J, editors. Ophthalmology. 4th ed. Philadelphia: Elsevier; 2014:687.
   Google Scholar
• Tran VT, Auer C, Guex-Crosier Y, Pittet N, Herbort CP. Epidemiology of uveitis in Switzerland. Ocul Immunol Inflamm. 1994;2(3):169–176. doi:10.3109/09273949409057073
   PubMedGoogle Scholar
• Paivonsalo-Hietanen T, Tuominen J, Vaahtoranta-Lehtonen H, Saari KM. Incidence and prevalence of different uveitis entities in Finland. Acta Ophthalmol Scand. 1997;75(1):76–81.
   PubMedGoogle Scholar
• Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103(2):234–235. doi:10.1016/s0002-9394(14)74235-7
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057
   PubMed Web of Science ®Google Scholar
• Deschenes J, Murray PI, Rao NA, Nussenblatt RB; International Uveitis Study Group. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16(1):1–2. doi:10.1080/09273940801899822
   PubMed Web of Science ®Google Scholar
• Yhuel Y, Weber M. Physiopathologie de l’oedème maculaire inflammatoire. In: Cohen S, Gaudric A, editors. Rétine. Les Ulis: Médecine Sciences Publications; 2012:184–189.
   Google Scholar
• Munk MR, Ram R, Rademaker A, et al. Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema. Acta Ophthalmol. 2015;93(7):e561–567. doi:10.1111/aos.12699
   PubMed Web of Science ®Google Scholar
• Tran TH, de Smet MD, Bodaghi B, Fardeau C, Cassoux N, Lehoang P. Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography. Br J Ophthalmol. 2008;92(7):922–927. doi:10.1136/bjo.2007.136846
   PubMed Web of Science ®Google Scholar
• Valentincic NV, de Groot-Mijnes JD, Kraut A, Korosec P, Hawlina M, Rothova A. Intraocular and serum cytokine profiles in patients with intermediate uveitis. Mol Vis. 2011;17:2003–2010.
   PubMed Web of Science ®Google Scholar
• Schafer DP, Lehrman EK, Kautzman AG, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74(4):691–705. doi:10.1016/j.neuron.2012.03.026
   PubMed Web of Science ®Google Scholar
• Stamer WD, Bok D, Hu J, Jaffe GJ, McKay BS. Aquaporin-1 channels in human retinal pigment epithelium: role in transepithelial water movement. Invest Ophthalmol Vis Sci. 2003;44(6):2803–2808. doi:10.1167/iovs.03-0001
   PubMed Web of Science ®Google Scholar
• de Smet MD. Insights into the physiopathology of inflammatory macular edema. Dev Ophthalmol. 2017;58:168–177. doi:10.1159/000455279
   PubMedGoogle Scholar
• Omri S, Behar-Cohen F, de Kozak Y, et al. Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCzeta in the Goto Kakizaki rat model. Am J Pathol. 2011;179(2):942–953. doi:10.1016/j.ajpath.2011.04.018
   PubMed Web of Science ®Google Scholar
• Fardeau C, Champion E, Massamba N, LeHoang P. Uveitic macular edema. Eye (Lond). 2016;30(10):1277–1292. doi:10.1038/eye.2016.115
   PubMed Web of Science ®Google Scholar
• Bringmann A, Pannicke T, Grosche J, et al. Muller cells in the healthy and diseased retina. Prog Retin Eye Res. 2006;25(4):397–424. doi:10.1016/j.preteyeres.2006.05.003
   PubMed Web of Science ®Google Scholar
• Pannicke T, Uckermann O, Iandiev I, Wiedemann P, Reichenbach A, Bringmann A. Ocular inflammation alters swelling and membrane characteristics of rat Muller glial cells. J Neuroimmunol. 2005;161(1–2):145–154. doi:10.1016/j.jneuroim.2005.01.003
   Web of Science ®Google Scholar
• Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol. 2002;47(Suppl 1):S203–S218.
   PubMed Web of Science ®Google Scholar
• Liu XQ, Kobayashi H, Jin ZB, Wada A, Nao IN. Differential expression of Kir4.1 and aquaporin 4 in the retina from endotoxin-induced uveitis rat. Mol Vis. 2007;13:309–317.
   PubMed Web of Science ®Google Scholar
• Gaudric A, Privat E. Ischémie choroïdienne aigue. In: CJ P, editor. Pathologies vasculaires oculaires. Paris (France): Société Française d’Ophtalmologie; 2008:555–571.
   Google Scholar
• Pavesio CE, Meier FM. Systemic disorders associated with episcleritis and scleritis. Curr Opin Ophthalmol. 2001;12(6):471–478.
   Web of Science ®Google Scholar
• Sharma SM, Jackson D. Uveitis and spondyloarthropathies. Best Pract Res Clin Rheumatol. 2017;31(6):846–862. doi:10.1016/j.berh.2018.08.002
   Web of Science ®Google Scholar
• Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Best Pract Res Clin Rheumatol. 2017;31(4):517–534. doi:10.1016/j.berh.2018.01.002
   PubMed Web of Science ®Google Scholar
• Salah S, Abad S, Monnet D, Brezin AP. Sarcoidosis. J Fr Ophtalmol. 2018;41(10):e451–e467. doi:10.1016/j.jfo.2018.10.002
   PubMed Web of Science ®Google Scholar
• Stubiger N, Ruprecht K, Pleyer U. [Intraocular inflammation in multiple sclerosis]. Ophthalmologe. 2018;115(6):531–542. doi:10.1007/s00347-018-0673-5
   Web of Science ®Google Scholar
• Chauhan K, Tripathy K. Pars planitis. In: StatPearls. Treasure Island (FL); 2018.
   Google Scholar
• Bazvand F, Zarei M, Ebrahimiadib N, et al. Ocular manifestations, conventional fundus fluorescein angiographic findings, and relationship between angiographic findings and visual acuity in Behcet’s disease. Semin Ophthalmol. 2017;32(6):764–771. doi:10.1080/08820538.2016.1178310
   PubMed Web of Science ®Google Scholar
• Cho H, Madu A. Etiology and treatment of the inflammatory causes of cystoid macular edema. J Inflamm Res. 2009;2:37–43.
   PubMedGoogle Scholar
• Zur D, Loewenstein A. Postsurgical cystoid macular edema. Dev Ophthalmol. 2017;58:178–190. doi:10.1159/000455280
   PubMedGoogle Scholar
• Zemba M, Camburu G. Uveitis-glaucoma-hyphaema syndrome. General review. Rom J Ophthalmol. 2017;61(1):11–17.
   Google Scholar
• Moorthy RS, Moorthy MS, Cunningham ET Jr. Drug-induced uveitis. Curr Opin Ophthalmol. 2018;29(6):588–603. doi:10.1097/ICU.0000000000000530
   PubMed Web of Science ®Google Scholar
• London NJ, Garg SJ, Moorthy RS, Cunningham ET. Drug-induced uveitis. J Ophthalmic Inflamm Infect. 2013;3(1):43. doi:10.1186/1869-5760-3-43
   PubMedGoogle Scholar
• Shoughy SS, Tabbara KF. Ocular findings in systemic lupus erythematosus. Saudi J Ophthalmol. 2016;30(2):117–121. doi:10.1016/j.sjopt.2016.02.001
   PubMedGoogle Scholar
• Shao EH, Menezo V, Taylor SR. Birdshot chorioretinopathy. Curr Opin Ophthalmol. 2014;25(6):488–494. doi:10.1097/ICU.0000000000000101
   Web of Science ®Google Scholar
• Castiblanco CP, Adelman RA. Sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol. 2009;247(3):289–302. doi:10.1007/s00417-008-0939-8
   PubMed Web of Science ®Google Scholar
• Choi JY, Kafkala C, Foster CS. Primary intraocular lymphoma: A review. Semin Ophthalmol. 2006;21(3):125–133. doi:10.1080/08820530500350498
   Google Scholar
• Bonnet C, Daudin JB, Monnet D, Brezin A. [Vogt-Koyanagi-Harada disease]. J Fr Ophtalmol. 2017;40(6):512–519. doi:10.1016/j.jfo.2017.02.006
   Web of Science ®Google Scholar
• Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80(4):332–336. doi:10.1136/bjo.80.4.332
   PubMed Web of Science ®Google Scholar
• Miserocchi E, Fogliato G, Modorati G, Bandello F. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013;23(5):705–717. doi:10.5301/ejo.5000278
   PubMed Web of Science ®Google Scholar
• Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111(3):491–500; discussion 500. doi:10.1016/j.ophtha.2003.06.014
   PubMed Web of Science ®Google Scholar
• Dandona L, Dandona R, John RK, McCarty CA, Rao GN. Population based assessment of uveitis in an urban population in southern India. Br J Ophthalmol. 2000;84(7):706–709. doi:10.1136/bjo.84.7.706
   PubMed Web of Science ®Google Scholar
• Ayanru JO. The problem of uveitis in Bendel State of Nigeria: experience in Benin City. Br J Ophthalmol. 1977;61(10):655–659. doi:10.1136/bjo.61.10.655
   PubMed Web of Science ®Google Scholar
• Yang P, Zhang Z, Zhou H, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30(11):943–948. doi:10.1080/02713680500263606
   PubMed Web of Science ®Google Scholar
• Wakabayashi T, Morimura Y, Miyamoto Y, Okada AA. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003;11(4):277–286.
   PubMed Web of Science ®Google Scholar
• Khairallah M, Yahia SB, Ladjimi A, et al. Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye (Lond). 2007;21(1):33–39. doi:10.1038/sj.eye.6702111
   PubMed Web of Science ®Google Scholar
• Thorne JE, Suhler E, Skup M, et al. Prevalence of noninfectious uveitis in the United States: a claims-based analysis. JAMA Ophthalmol. 2016;134(11):1237–1245. doi:10.1001/jamaophthalmol.2016.3229
   PubMed Web of Science ®Google Scholar
• Bodaghi B, Cassoux N, Wechsler B, et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore). 2001;80(4):263–270. doi:10.1097/00005792-200107000-00005
   PubMed Web of Science ®Google Scholar
• Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16. doi:10.1080/09273948.2016.1196713
   PubMed Web of Science ®Google Scholar
• Smit RL, Baarsma GS, de Vries J. Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol. 1993;17(2):71–76.
   PubMed Web of Science ®Google Scholar
• Mercanti A, Parolini B, Bonora A, Lequaglie Q, Tomazzoli L. Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. Acta Ophthalmol Scand. 2001;79(1):64–68.
   PubMedGoogle Scholar
• Chang JH, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm. 2002;10(4):263–279.
   PubMed Web of Science ®Google Scholar
• Biswas J, Narain S, Das D, Ganesh SK. Pattern of uveitis in a referral uveitis clinic in India. Int Ophthalmol. 1996;20(4):223–228.
   PubMed Web of Science ®Google Scholar
• Perkins ES, Folk J. Uveitis in London and Iowa. Ophthalmologica. 1984;189(1–2):36–40. doi:10.1159/000309382
   Web of Science ®Google Scholar
• Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol. 1987;103(2):131–136. doi:10.1016/s0002-9394(14)74217-5
   PubMed Web of Science ®Google Scholar
• McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG; UCLA Community-Based Uveitis Study Group. Causes of uveitis in the general practice of ophthalmology. Am J Ophthalmol. 1996;121(1):35–46. doi:10.1016/s0002-9394(14)70532-x
   PubMed Web of Science ®Google Scholar
• Thean LH, Thompson J, Rosenthal AR. A uveitis register at the Leicester Royal Infirmary. Ophthalmic Epidemiol. 1996;3(3):151–158.
   PubMedGoogle Scholar
• Munoz-Fernandez S, Martin-Mola E. Uveitis. Best Pract Res Clin Rheumatol. 2006;20(3):487–505. doi:10.1016/j.berh.2006.03.008
   PubMed Web of Science ®Google Scholar
• Grajewski RS, Boelke AC, Adler W, et al. Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis. Eye (Lond). 2016;30(11):1415–1423. doi:10.1038/eye.2016.133
   PubMed Web of Science ®Google Scholar
• de Smet MD, Okada AA. Cystoid macular edema in uveitis. Dev Ophthalmol. 2010;47:136–147. doi:10.1159/000320077
   PubMedGoogle Scholar
• de Boer J, Steijaert A, van den Bor R, Stellato R, Ossewaarde-van Norel J. Development of macular edema and impact on visual acuity in uveitis associated with juvenile idiopathic arthritis. Ocul Immunol Inflamm. 2015;23(1):67–73. doi:10.3109/09273948.2013.871566
   PubMed Web of Science ®Google Scholar
• Lardenoye CW, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology. 2006;113(8):1446–1449. doi:10.1016/j.ophtha.2006.03.027
   PubMed Web of Science ®Google Scholar
• Levin MH, Pistilli M, Daniel E, et al. Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema. Ophthalmology. 2014;121(2):588–595 e581. doi:10.1016/j.ophtha.2013.09.023
   PubMed Web of Science ®Google Scholar
• Pivetti-Pezzi P, Accorinti M, La Cava M, Colabelli Gisoldi RA, Abdulaziz MA. Endogenous uveitis: an analysis of 1,417 cases. Ophthalmologica. 1996;210(4):234–238. doi:10.1159/000310715
   PubMed Web of Science ®Google Scholar
• Bajwa A, Osmanzada D, Osmanzada S, et al. Epidemiology of uveitis in the mid-Atlantic United States. Clin Ophthalmol. 2015;9:889–901. doi:10.2147/OPTH.S80972
   PubMed Web of Science ®Google Scholar
• Birnbaum AD, French DD, Mirsaeidi M, Wehrli S. Sarcoidosis in the national veteran population: association of ocular inflammation and mortality. Ophthalmology. 2015;122(5):934–938. doi:10.1016/j.ophtha.2015.01.003
   PubMed Web of Science ®Google Scholar
• Merle H, Cabre P, Olindo S, Merle S, Smadja D. Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies). Am J Ophthalmol. 2002;134(2):190–195. doi:10.1016/s0002-9394(02)01521-0
   PubMed Web of Science ®Google Scholar
• Wakefield D, Chang JH. Epidemiology of uveitis. Int Ophthalmol Clin. 2005;45(2):1–13.
   PubMedGoogle Scholar
• Merrill PT, Kim J, Cox TA, Betor CC, McCallum RM, Jaffe GJ. Uveitis in the southeastern United States. Curr Eye Res. 1997;16(9):865–874.
   PubMed Web of Science ®Google Scholar
• Aydin T, Taspinar O, Guneser M, Keskin Y. Association of Vogt Koyanagi Harada syndrome and seronegative rheumatoid arthritis. Ethiop J Health Sci. 2016;26(2):193–196. doi:10.4314/ejhs.v26i2.14
   Google Scholar
• Nashtaei EM, Soheilian M, Herbort CP, Yaseri M. Patterns of uveitis in the middle East and europe. J Ophthalmic Vis Res. 2011;6(4):233–240.
   Google Scholar
• Lee JH, Mi H, Lim R, et al. Ocular autoimmune systemic inflammatory infectious study - report 3: posterior and panuveitis. Ocul Immunol Inflamm. 2019;27(1):89–98. doi: 10.1080/09273948.2017.1358377
   Google Scholar
• Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology. 1998;105(9):1646–1651. doi:10.1016/S0161-6420(98)99033-9
   PubMed Web of Science ®Google Scholar
• Linssen A, Meenken C. Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis. Am J Ophthalmol. 1995;120(3):351–361. doi:10.1016/s0002-9394(14)72165-8
   PubMed Web of Science ®Google Scholar
• Braakenburg AM, de Valk HW, de Boer J, Rothova A. Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences. Am J Ophthalmol. 2008;145(3):472–479. doi:10.1016/j.ajo.2007.11.009
   PubMed Web of Science ®Google Scholar
• Hoeksema L, Los LI. Visual prognosis and ocular complications in herpetic versus HLA-B27- or ankylosing spondylitis-associated anterior uveitis. Ocul Immunol Inflamm. 2016;24(3):302–312. doi:10.3109/09273948.2015.1005237
   PubMed Web of Science ®Google Scholar
• Accorinti M, Iannetti L, Liverani M, Caggiano C, Gilardi M. Clinical features and prognosis of HLA B27-associated acute anterior uveitis in an Italian patient population. Ocul Immunol Inflamm. 2010;18(2):91–96. doi:10.3109/09273941003597268
   PubMed Web of Science ®Google Scholar
• Pathanapitoon K, Suksomboon S, Kunavisarut P, et al. HLA-B27-associated acute anterior uveitis in the University Referral Centre in North Thailand: clinical presentation and visual prognosis. Br J Ophthalmol. 2006;90(12):1448–1450. doi:10.1136/bjo.2006.099788
   PubMed Web of Science ®Google Scholar
• Sungur G, Yakin M, Uzman S, Balta O, Orman G, Ornek F. Clinical features and prognosis of uveitis in a Turkish patient population with ankylosing spondylitis: incidence and management of ocular complications. Ocul Immunol Inflamm. 2019;27(4):551–559. doi: 10.1080/09273948.2018.1431290
   Google Scholar
• Angeles-Han ST, McCracken C, Yeh S, et al. Characteristics of a cohort of children with juvenile idiopathic arthritis and JIA-associated uveitis. Pediatr Rheumatol Online J. 2015;13:19. doi:10.1186/s12969-015-0018-8
   PubMed Web of Science ®Google Scholar
• Heinz C, Schoonbrood S, Heiligenhaus A. Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome. Br J Ophthalmol. 2014;98(8):1107–1111. doi:10.1136/bjophthalmol-2013-304589
   PubMed Web of Science ®Google Scholar
• Paroli MP, Spinucci G, Monte R, Pesci FR, Abicca I, Pivetti Pezzi P. Intermediate uveitis in a pediatric Italian population. Ocul Immunol Inflamm. 2011;19(5):321–326. doi:10.3109/09273948.2011.603878
   PubMed Web of Science ®Google Scholar
• de Boer J, Berendschot TT, van der Does P, Rothova A. Long-term follow-up of intermediate uveitis in children. Am J Ophthalmol. 2006;141(4):616–621. doi:10.1016/j.ajo.2005.09.035
   PubMed Web of Science ®Google Scholar
• Arellanes-Garcia L, Navarro-Lopez L, Recillas-Gispert C. Pars planitis in the Mexican Mestizo population: ocular findings, treatment, and visual outcome. Ocul Immunol Inflamm. 2003;11(1):53–60.
   PubMed Web of Science ®Google Scholar
• Accorinti M, Pesci FR, Pirraglia MP, Abicca I, Pivetti-Pezzi P. Ocular Behcet’s disease: changing patterns over time, complications and long-term visual prognosis. Ocul Immunol Inflamm. 2017;25(1):29–36. doi:10.3109/09273948.2015.1094095
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138(3):373–380. doi:10.1016/j.ajo.2004.03.022
   PubMed Web of Science ®Google Scholar
• Accorinti M, Okada AA, Smith JR, Gilardi M. Epidemiology of macular edema in uveitis. Ocul Immunol Inflamm. 2019;27(2):169–180. doi: 10.1080/09273948.2019.1576910
   Google Scholar
• Gupta V, Al-Dhibi HA, Arevalo JF. Retinal imaging in uveitis. Saudi J Ophthalmol. 2014;28(2):95–103. doi:10.1016/j.sjopt.2014.02.008
   PubMedGoogle Scholar
• Gaucher D, Tadayoni R, Erginay A, Haouchine B, Gaudric A, Massin P. Optical coherence tomography assessment of the vitreoretinal relationship in diabetic macular edema. Am J Ophthalmol. 2005;139(5):807–813. doi:10.1016/j.ajo.2004.12.084
   PubMed Web of Science ®Google Scholar
• Grewal DS, O’Sullivan ML, Kron M, Jaffe GJ. Association of disorganization of retinal inner layers with visual acuity in eyes with uveitic cystoid macular edema. Am J Ophthalmol. 2017;177:116–125. doi:10.1016/j.ajo.2017.02.017
   PubMed Web of Science ®Google Scholar
• Roesel M, Henschel A, Heinz C, Dietzel M, Spital G, Heiligenhaus A. Fundus autofluorescence and spectral domain optical coherence tomography in uveitic macular edema. Graefes Arch Clin Exp Ophthalmol. 2009;247(12):1685–1689. doi:10.1007/s00417-009-1149-8
   PubMed Web of Science ®Google Scholar
• Thomas AS, Redd T, Campbell JP, et al. The impact and implication of peripheral vascular leakage on ultra-widefield fluorescein angiography in uveitis. Ocul Immunol Inflamm. 2019;27(3):349–355. doi: 10.1080/09273948.2017.1367406
   Google Scholar
• Karampelas M, Sim DA, Chu C, et al. Quantitative analysis of peripheral vasculitis, ischemia, and vascular leakage in uveitis using ultra-widefield fluorescein angiography. Am J Ophthalmol. 2015;159(6):1161–1168 e1161. doi:10.1016/j.ajo.2015.02.009
   PubMed Web of Science ®Google Scholar
• Campbell JP, Leder HA, Sepah YJ, et al. Wide-field retinal imaging in the management of noninfectious posterior uveitis. Am J Ophthalmol. 2012;154(5):908–911 e902. doi:10.1016/j.ajo.2012.05.019
   PubMed Web of Science ®Google Scholar
• Willis MA, Cohen JA. Fingolimod therapy for multiple sclerosis. Semin Neurol. 2013;33(1):37–44. doi:10.1055/s-0033-1343794
   PubMed Web of Science ®Google Scholar
• Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol. 2006;124(2):193–198. doi:10.1001/archopht.124.2.193
   PubMedGoogle Scholar
• Kozak I, Morrison VL, Clark TM, et al. Discrepancy between fluorescein angiography and optical coherence tomography in detection of macular disease. Retina. 2008;28(4):538–544. doi:10.1097/IAE.0b013e318167270b
   PubMed Web of Science ®Google Scholar
• Rahman HT, Yeh S, Bergstrom CS. Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab. J Ocul Pharmacol Ther. 2013;29(3):360–362. doi:10.1089/jop.2011.0178
   Web of Science ®Google Scholar
• Nayak SK, Jeloka TK, Sreepada SV. Sirolimus-induced pneumonitis, sinusitis and macular oedema. Nephrol Dial Transplant. 2004;19(11):2931. doi:10.1093/ndt/gfh465
   Web of Science ®Google Scholar
• Yeh S, Forooghian F, Wong WT, et al. Fundus autofluorescence imaging of the white dot syndromes. Arch Ophthalmol. 2010;128(1):46–56. doi:10.1001/archophthalmol.2009.368
   PubMedGoogle Scholar
• de-la-Torre A, Valdes-Camacho J, de Mesa CL, et al. Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin. BMC Infect Dis. 2019;19(1):91. doi:10.1186/s12879-018-3613-8
   PubMed Web of Science ®Google Scholar
• Shaikh SI, Biswas J, Rishi P. Nodular syphilitic scleritis masquerading as an ocular tumor. J Ophthalmic Inflamm Infect. 2015;5:8. doi:10.1186/s12348-015-0040-5
   PubMed Web of Science ®Google Scholar
• Thorne JE, Brucker AJ. Choroidal white lesions as an early manifestation of sarcoidosis. Retina. 2000;20(1):8–15.
   Web of Science ®Google Scholar
• Margolis R. Diagnostic vitrectomy for the diagnosis and management of posterior uveitis of unknown etiology. Curr Opin Ophthalmol. 2008;19(3):218–224. doi:10.1097/ICU.0b013e3282fc261d
   PubMed Web of Science ®Google Scholar
• Rothova A, de Boer JH, Ten Dam-van Loon NH, et al. Usefulness of aqueous humor analysis for the diagnosis of posterior uveitis. Ophthalmology. 2008;115(2):306–311. doi:10.1016/j.ophtha.2007.05.014
   PubMed Web of Science ®Google Scholar
• Kojima K, Maruyama K, Inaba T, et al. The CD4/CD8 ratio in vitreous fluid is of high diagnostic value in sarcoidosis. Ophthalmology. 2012;119(11):2386–2392. doi:10.1016/j.ophtha.2012.05.033
   PubMed Web of Science ®Google Scholar
• Maruyama K, Inaba T, Sugita S, et al. Comprehensive analysis of vitreous specimens for uveitis classification: a prospective multicentre observational study. BMJ Open. 2017;7(11):e014549.
   PubMed Web of Science ®Google Scholar
• Pochat-Cotilloux C, Bienvenu J, Nguyen AM, et al. Use of a threshold of interleukin-10 and Il-10/Il-6 ratio in ocular samples for the screening of vitreoretinal lymphoma. Retina. 2018;38(4):773–781. doi:10.1097/IAE.0000000000001922
   PubMed Web of Science ®Google Scholar
• Wielders LHP, Schouten J, Winkens B, et al. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1. J Cataract Refract Surg. 2018;44(4):429–439. doi:10.1016/j.jcrs.2018.01.029
   PubMed Web of Science ®Google Scholar
• Wielders LHP, Schouten J, Winkens B, et al. Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED Study Report 2. J Cataract Refract Surg. 2018;44(7):836–847. doi:10.1016/j.jcrs.2018.05.015
   PubMed Web of Science ®Google Scholar
• Sanders DR, Kraff M. Steroidal and nonsteroidal anti-inflammatory agents. Effect on postsurgical inflammation and blood-aqueous humor barrier breakdown. Arch Ophthalmol. 1984;102(10):1453–1456. doi:10.1001/archopht.1984.01040031173012
   PubMedGoogle Scholar
• Young PW, Shea M. Pars plasma vitrectomy in the management of the Irvine-Gass syndrome. Can J Ophthalmol. 1980;15(4):172–175.
   PubMed Web of Science ®Google Scholar
• Lardenoye CW, van Schooneveld MJ, Frits Treffers W, Rothova A. Grid laser photocoagulation for macular oedema in uveitis or the Irvine-Gass syndrome. Br J Ophthalmol. 1998;82(9):1013–1016. doi:10.1136/bjo.82.9.1013
   Web of Science ®Google Scholar
• Loewenstein A, Zur D. Postsurgical cystoid macular edema. Dev Ophthalmol. 2010;47:148–159. doi:10.1159/000320078
   PubMedGoogle Scholar
• Thorne JE, Sugar EA, Holbrook JT, et al. Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial. Ophthalmology. 2019;126(2):283–295. doi:10.1016/j.ophtha.2018.08.021
   PubMed Web of Science ®Google Scholar
• Mitropoulos PG, Chatziralli IP, Peponis VG, Drakos E, Parikakis EA. Intravitreal ranibizumab for the treatment of Irvine-Gass syndrome. Ocul Immunol Inflamm. 2015;23(3):225–231. doi:10.3109/09273948.2014.898775
   Web of Science ®Google Scholar
• Arevalo JF, Maia M, Garcia-Amaris RA, et al. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Ophthalmology. 2009;116(8):1481–1487, 1487 e1481. doi:10.1016/j.ophtha.2009.04.006
   PubMed Web of Science ®Google Scholar
• Malcles A, Janin-Manificat H, Yhuel Y, et al. [Anterior chamber migration of intravitreal dexamethasone implant (Ozurdex(R)) in pseudophakic eyes: report of three cases]. J Fr Ophtalmol. 2013;36(4):362–367. doi:10.1016/j.jfo.2012.11.003
   Web of Science ®Google Scholar
• Bahadorani S, Krambeer C, Wannamaker K, et al. The effects of repeated Ozurdex injections on ocular hypertension. Clin Ophthalmol. 2018;12:639–642. doi:10.2147/OPTH.S148990
   PubMed Web of Science ®Google Scholar
• Massa H, Georgoudis P, Panos GD. Dexamethasone intravitreal implant (OZURDEX((R))) for macular edema secondary to noninfectious uveitis: a review of the literature. Ther Deliv. 2019;10(6):343–351. doi:10.4155/tde-2019-0024
   PubMed Web of Science ®Google Scholar
• Bellocq D, Korobelnik JF, Burillon C, et al. Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study. Br J Ophthalmol. 2015;99(7):979–983. doi:10.1136/bjophthalmol-2014-306159
   PubMed Web of Science ®Google Scholar
• Warren KA, Bahrani H, Fox JE. NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. Retina. 2010;30(2):260–266.
   PubMed Web of Science ®Google Scholar
• Massa HF, Gobej I, Jacquier P, Jonescu-Cuypers C, Le Quoy O. Cystoid macular oedema and iris-fixated intraocular lens treated with intraocular lens exchange: a case series and review. J Int Med Res. 2019;47(1):188–195. doi:10.1177/0300060518799004
   Web of Science ®Google Scholar
• Matet A, Daruich A, Behar-Cohen F. Irvine-Gass macular edema responding to the combination of oral mineralocorticoid-receptor antagonist with dexamethasone drops. Ophthalmic Surg Lasers Imaging Retina. 2017;48(11):936–942. doi:10.3928/23258160-20171030-11
   Web of Science ®Google Scholar
• Deuter CM, Gelisken F, Stubiger N, Zierhut M, Doycheva D. Successful treatment of chronic pseudophakic macular edema (Irvine-Gass syndrome) with interferon alpha: a report of three cases. Ocul Immunol Inflamm. 2011;19(3):216–218. doi:10.3109/09273948.2011.562341
   PubMed Web of Science ®Google Scholar
• Nirankari VS, Karesh JW. Cystoid macular edema following penetrating keratoplasty: incidence and prognosis. Ophthalmic Surg. 1986;17(7):404–407.
   Google Scholar
• Kocaba V, Mouchel R, Fleury J, et al. Incidence of cystoid macular edema after descemet membrane endothelial keratoplasty. Cornea. 2018;37(3):277–282. doi:10.1097/ICO.0000000000001501
   PubMed Web of Science ®Google Scholar
• Kitazawa K, Kayukawa K, Wakimasu K, et al. Topical non-steroidal anti-inflammatory drugs for the treatment of cystoid macular edema post Descemet’s stripping automated endothelial keratoplasty. Jpn J Ophthalmol. 2018;62(6):615–620. doi:10.1007/s10384-018-0621-6
   Web of Science ®Google Scholar
• Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130(4):492–513. doi:10.1016/s0002-9394(00)00659-0
   PubMed Web of Science ®Google Scholar
• Hogan AC, McAvoy CE, Dick AD, Lee RW. Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis. Ophthalmology. 2007;114(5):1000–1006. doi:10.1016/j.ophtha.2007.01.026
   PubMed Web of Science ®Google Scholar
• Bacon PA, Salmon M. Modes of action of second-line agents. Scand J Rheumatol Suppl. 1987;64:17–24.
   Google Scholar
• Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology. 2005;112(8):1472–1477. doi:10.1016/j.ophtha.2005.02.020
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Palestine AG, Chan CC. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol. 1983;96(3):275–282. doi:10.1016/s0002-9394(14)77814-6
   PubMed Web of Science ®Google Scholar
• Gillies MC, Su T. Interferon-alpha 2b enhances barrier function of bovine retinal microvascular endothelium in vitro. Microvasc Res. 1995;49(3):277–288. doi:10.1006/mvre.1995.1024
   PubMed Web of Science ®Google Scholar
• Feron EJ, Rothova A, van Hagen PM, Baarsma GS, Suttorp-Schulten MS. Interferon-alpha 2b for refractory ocular Behcet’s disease. Lancet. 1994;343(8910):1428. doi:10.1016/S0140-6736(94)92549-6
   PubMed Web of Science ®Google Scholar
• Neri P, Mariotti C, Cimino L, Mercanti L, Giovannini A. Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil. Int Ophthalmol. 2009;29(3):127–133. doi:10.1007/s10792-008-9200-z
   PubMedGoogle Scholar
• Ramanan AV, Dick AD, Jones AP, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017;376(17):1637–1646. doi:10.1056/NEJMoa1614160
   PubMed Web of Science ®Google Scholar
• Trivedi A, Katelaris C. The use of biologic agents in the management of uveitis. Intern Med J. 2018. doi:10.1111/imj.14215
   Web of Science ®Google Scholar
• Yanai R, Takeda A, Yoshimura T, Sonoda KH. [Pathophysiology and new treatment of uveitis]. Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(2):74–82.
   Google Scholar
• Tallouzi MO, Mathers JM, Moore DJ, et al. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis. Trials. 2017;18(1):576. doi:10.1186/s13063-017-2294-8
   PubMed Web of Science ®Google Scholar
• Tallouzi MO, Moore DJ, Calvert M, Murray PI, Bucknall N, Denniston AK. The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol. Syst Rev. 2016;5:29. doi:10.1186/s13643-016-0289-2
   Google Scholar
• Sharma SM, Nestel AR, Lee RW, Dick AD. Clinical review: anti-TNFalpha therapies in uveitis: perspective on 5 years of clinical experience. Ocul Immunol Inflamm. 2009;17(6):403–414. doi:10.3109/09273940903072443
   PubMed Web of Science ®Google Scholar
• Markomichelakis NN, Theodossiadis PG, Pantelia E, Papaefthimiou S, Theodossiadis GP, Sfikakis PP. Infliximab for chronic cystoid macular edema associated with uveitis. Am J Ophthalmol. 2004;138(4):648–650. doi:10.1016/j.ajo.2004.04.066
   PubMed Web of Science ®Google Scholar
• Schaap-Fogler M, Amer R, Friling R, Priel E, Kramer M. Anti-TNF-alpha agents for refractory cystoid macular edema associated with noninfectious uveitis. Graefes Arch Clin Exp Ophthalmol. 2014;252(4):633–640. doi:10.1007/s00417-013-2552-8
   PubMed Web of Science ®Google Scholar
• Arida A, Fragiadaki K, Giavri E, Sfikakis PP. Anti-TNF agents for Behcet’s disease: analysis of published data on 369 patients. Semin Arthritis Rheum. 2011;41(1):61–70. doi:10.1016/j.semarthrit.2010.09.002
   PubMed Web of Science ®Google Scholar
• Vallet H, Seve P, Biard L, et al. Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the french uveitis network. Arthritis Rheumatol. 2016;68(6):1522–1530. doi:10.1002/art.39667
   PubMed Web of Science ®Google Scholar
• Diaz-Llopis M, Salom D, Garcia-de-Vicuna C, et al. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients. Ophthalmology. 2012;119(8):1575–1581. doi:10.1016/j.ophtha.2012.02.018
   PubMed Web of Science ®Google Scholar
• Calvo-Rio V, Blanco R, Beltran E, et al. Anti-TNF-alpha therapy in patients with refractory uveitis due to Behcet’s disease: a 1-year follow-up study of 124 patients. Rheumatology (Oxford). 2014;53(12):2223–2231. doi:10.1093/rheumatology/keu266
   PubMed Web of Science ®Google Scholar
• Mesquida M, Molins B, Llorenc V, et al. Twenty-four month follow-up of tocilizumab therapy for refractory uveitis-related macular edema. Retina. 2018;38(7):1361–1370. doi:10.1097/IAE.0000000000001690
   PubMed Web of Science ®Google Scholar
• Calvo-Rio V, Blanco R, Santos-Gomez M, et al. Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients. Semin Arthritis Rheum. 2016;46(1):95–101. doi:10.1016/j.semarthrit.2016.03.002
   PubMed Web of Science ®Google Scholar
• Riancho-Zarrabeitia L, Calvo-Rio V, Blanco R, et al. Anti-TNF-alpha therapy in refractory uveitis associated with sarcoidosis: multicenter study of 17 patients. Semin Arthritis Rheum. 2015;45(3):361–368. doi:10.1016/j.semarthrit.2015.05.010
   PubMed Web of Science ®Google Scholar
• Galor A, Perez VL, Hammel JP, Lowder CY. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology. 2006;113(12):2317–2323. doi:10.1016/j.ophtha.2006.04.038
   PubMed Web of Science ®Google Scholar
• Imrie FR, Dick AD. Biologics in the treatment of uveitis. Curr Opin Ophthalmol. 2007;18(6):481–486. doi:10.1097/ICU.0b013e3282f03d42
   PubMed Web of Science ®Google Scholar
• Taylor SR, Habot-Wilner Z, Pacheco P, Lightman SL. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema. Ophthalmology. 2009;116(4):797–801. doi:10.1016/j.ophtha.2008.10.033
   PubMed Web of Science ®Google Scholar
• Golan S, Loewenstein A. Surgical treatment for macular edema. Semin Ophthalmol. 2014;29(4):242–256. doi:10.3109/08820538.2013.796394
   PubMed Web of Science ®Google Scholar
• Muhaya M, Calder VL, Towler HM, Jolly G, McLauchlan M, Lightman S. Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man. Clin Exp Immunol. 1999;116(3):410–414. doi:10.1046/j.1365-2249.1999.00921.x
   PubMed Web of Science ®Google Scholar
• Liew G, Strong S, Bradley P, et al. Prevalence of cystoid macular oedema, epiretinal membrane and cataract in retinitis pigmentosa. Br J Ophthalmol. 2018. doi:10.1136/bjophthalmol-2018-311964
   Web of Science ®Google Scholar
• Dutta Majumder P, Menia N, Roy R, et al. Uveitis in patients with retinitis pigmentosa: 30 years’ consecutive data. Ocul Immunol Inflamm. 2018;26(8):1283–1288. doi:10.1080/09273948.2017.1348527
   PubMed Web of Science ®Google Scholar
• Moldow B, Sander B, Larsen M, et al. The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. Graefes Arch Clin Exp Ophthalmol. 1998;236(12):881–889.
   Web of Science ®Google Scholar
• Grover S, Fishman GA, Fiscella RG, Adelman AE. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Retina. 1997;17(3):222–231.
   PubMed Web of Science ®Google Scholar
• Saraiva VS, Sallum JM, Farah ME. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging. 2003;34(5):398–400.
   PubMedGoogle Scholar
• Menezo V, Taylor SR. Birdshot uveitis: current and emerging treatment options. Clin Ophthalmol. 2014;8:73–81. doi:10.2147/OPTH.S54832
   PubMedGoogle Scholar
• Jaffe GJ, Dick AD, Brezin AP, et al. Adalimumab in patients with active noninfectious uveitis. N Engl J Med. 2016;375(10):932–943. doi:10.1056/NEJMoa1509852
   PubMed Web of Science ®Google Scholar
• Leclercq M, Le Besnerais M, Langlois V, et al. Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review. Clin Rheumatol. 2018;37(3):849–853. doi:10.1007/s10067-018-4007-4
   PubMed Web of Science ®Google Scholar
• Hassall MM, Andrew NH. Single-eye trial of a topical carbonic anhydrase inhibitor versus intravitreal bevacizumab for the treatment of taxane drug-induced cystoid macula oedema. BMJ Case Rep. 2016;2016. doi:10.1136/bcr-2015-212733
   Google Scholar
• Kanakis M, Georgalas I, Makatsoris T, Pharmakakis N. Taxane induced cystoid macular edema: case report and integrated pathogenic theory. Curr Drug Saf. 2019;14(1):43–47. doi:10.2174/1574886313666180828163016
   Web of Science ®Google Scholar
• Matsuoka N, Hasebe H, Mayama T, Fukuchi T. Sub-tenon injections of triamcinolone acetonide had limited effect on cystoid macular edema secondary to nanoparticle albumin-bound-paclitaxel (Abraxane). Case Rep Ophthalmol Med. 2015;2015:181269. doi:10.1155/2015/181269
   PubMed Web of Science ®Google Scholar
• Turaka K, Bryan JS. Does fingolimod in multiple sclerosis patients cause macular edema? J Neurol. 2012;259(2):386–388. doi:10.1007/s00415-011-6367-4
   Web of Science ®Google Scholar
• Jain N, Bhatti MT. Fingolimod-associated macular edema: incidence, detection, and management. Neurology. 2012;78(9):672–680. doi:10.1212/WNL.0b013e318248deea
   PubMed Web of Science ®Google Scholar
• Chui J, Herkes GK, Chang A. Management of fingolimod-associated macular edema. JAMA Ophthalmol. 2013;131(5):694–696. doi:10.1001/jamaophthalmol.2013.47
   PubMed Web of Science ®Google Scholar
• Minuk A, Belliveau MJ, Almeida DR, Dorrepaal SJ, Gale JS. Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use. JAMA Ophthalmol. 2013;131(6):802–804. doi:10.1001/jamaophthalmol.2013.2465
   PubMed Web of Science ®Google Scholar
• Albaroudi N, Tijani M, Boutimzine N, Cherkaoui O, Laghmari M. [Prognostic factors in uveitis]. J Fr Ophtalmol. 2017;40(9):751–757. doi:10.1016/j.jfo.2017.04.005
   Web of Science ®Google Scholar
• Takeuchi M, Kanda T, Kaburaki T, et al. Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: a multicenter study. Medicine (Baltimore). 2019;98(9):e14668. doi:10.1097/MD.0000000000014668
   Web of Science ®Google Scholar
• Matas J, Llorenc V, Fonollosa A, et al. Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis. PLoS One. 2019;14(1):e0210799. doi:10.1371/journal.pone.0210799
   PubMed Web of Science ®Google Scholar
• Eiger-Moscovich M, Tomkins-Netzer O, Amer R, et al. Visual and clinical outcome of macular edema complicating pediatric noninfectious uveitis. Am J Ophthalmol. 2019;202:72–78. doi:10.1016/j.ajo.2019.02.011
   PubMed Web of Science ®Google Scholar
• Garweg JG. Macular edema in childhood uveitis. Klin Monbl Augenheilkd. 2018;235(4):373–376. doi:10.1055/s-0043-123650
   Web of Science ®Google Scholar
• Leinonen S, Immonen I, Kotaniemi K. Fluocinolone acetonide intravitreal implant (Retisert((R))) in the treatment of sight threatening macular oedema of juvenile idiopathic arthritis-related uveitis. Acta Ophthalmol. 2018;96(6):648–651. doi:10.1111/aos.13744
   PubMed Web of Science ®Google Scholar
• Kaleemunnisha S, Sudharshan S, Biswas J. Quality of life in non-infectious uveitis patients on immunosuppressive therapy. Middle East Afr J Ophthalmol. 2014;21(3):225–231. doi:10.4103/0974-9233.134675
   PubMedGoogle Scholar
• Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88(9):1159–1162. doi:10.1136/bjo.2003.037226
   PubMed Web of Science ®Google Scholar
• Taylor SR, Lightman SL, Sugar EA, et al. The impact of macular edema on visual function in intermediate, posterior, and panuveitis. Ocul Immunol Inflamm. 2012;20(3):171–181. doi:10.3109/09273948.2012.658467
   PubMed Web of Science ®Google Scholar
• Multicenter Uveitis Steroid Treatment Trial Follow-up Study Research G. Quality of life and risks associated with systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, or panuveitis: fifty-four-month results of the multicenter uveitis steroid treatment trial and follow-up study. Ophthalmology. 2015;122(10):1976–1986. doi:10.1016/j.ophtha.2015.06.043
   Web of Science ®Google Scholar
• Baughman RP, Barney JB, O’Hare L, Lower EE. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients. Respir Med. 2016;110:66–72. doi:10.1016/j.rmed.2015.11.007
   PubMed Web of Science ®Google Scholar
• Taylor PC, Abdul Azeez M, Kiriakidis S. Filgotinib for the treatment of rheumatoid arthritis. Expert Opin Investig Drugs. 2017;26(10):1181–1187. doi:10.1080/13543784.2017.1372422
   PubMed Web of Science ®Google Scholar
• Koronis S, Stavrakas P, Balidis M, Kozeis N, Tranos PG. Update in treatment of uveitic macular edema. Drug Des Devel Ther. 2019;13:667–680. doi:10.2147/DDDT.S166092
   PubMed Web of Science ®Google Scholar
• Feagan BG, Sandborn WJ, Gasink C, et al. Ustekinumab as induction and maintenance therapy for Crohn’s disease. N Engl J Med. 2016;375(20):1946–1960. doi:10.1056/NEJMoa1602773
   PubMed Web of Science ®Google Scholar
• Lopez-Ferrer A, Laiz A, Puig L. The safety of ustekinumab for the treatment of psoriatic arthritis. Expert Opin Drug Saf. 2017;16(6):733–742. doi:10.1080/14740338.2017.1323864
   PubMed Web of Science ®Google Scholar